18F - PSMA PET CT
₹24000
Book your 18F PSMA PET-CT scan appointment with Molecular Diagnostics and Therapy, a NABL- and NABH-accredited diagnostic centre offering state-of-the-art services in Nuclear Medicine, Radiology, and Pathology. This specialized PET-CT scan employs Fluorine-18 PSMA (18F-PSMA), which is a PET marker that targets Prostate-Specific Membrane Antigen (PSMA), a molecule that is expressed in prostate cancer. PET gives information on function, and CT gives information on detailed anatomy. Advanced PET-CT technology and compliance with radiation safety protocols are followed by our expert nuclear medicine physicians to ensure precise diagnosis, staging, treatment planning, and follow-up.
About 18F-PSMA PET-CT
The 18F-PSMA PET-CT Scan is a specialized nuclear medicine examination mainly used for the evaluation of prostate cancer. PSMA is targeted by the 18F-PSMA tracer, which is detected on PET imaging, and regions of abnormal uptake are identified. At Molecular Diagnostics and Therapy, we use state-of-the-art PET-CT technology to give the physician both functional and anatomic information for determining the location and extent of prostate cancer.
What is an 18F-PSMA PET-CT?
In an 18F-PSMA PET-CT, a tiny dose of radioactive 18F-PSMA tracer is injected into a vein. The patient then lies on the PET-CT scanner for a suitable uptake period for whole-body imaging. The PET component identifies regions with high PSMA activity, and the CT component gives detailed anatomical information. The composite photographs assist physicians in determining the position and likely spread of prostate cancer.
Common Reasons for 18F - PSMA PET-CT
- Detection of prostate cancer
- Staging of prostate cancer
- Evaluation of suspected recurrence
- Detection of metastatic disease
- Assessment of rising PSA levels
- Localization of PSMA-positive lesions
- Treatment planning
- Follow-up after prostate cancer treatment
Conditions Evaluated
Prostate Cancer
Helps detect and localize PSMA-expressing prostate cancer lesions.
Recurrent Prostate Cancer
Supports evaluation of suspected recurrence, particularly when PSA levels rise after treatment.
Metastatic Prostate Cancer
Helps identify possible spread of prostate cancer to lymph nodes, bones, and other sites.
Lymph Node Involvement
Can help identify PSMA-positive lymph node lesions for disease staging.
Bone Metastases
Helps identify PSMA-expressing prostate cancer deposits involving the bones.
Who Should Consider This Scan?
Your doctor recommends an 18F-PSMA PET-CT Scan if you:
- Have suspected or confirmed prostate cancer
- Need staging before treatment
- Have rising PSA after treatment
- Have suspected recurrent disease
- Need evaluation for metastatic prostate cancer
- Require assessment of PSMA-positive lesions
Benefits of 18F - PSMA PET-CT
- Provides whole-body functional imaging
- Helps detect PSMA-expressing lesions
- Combines PET functional information with CT anatomy
- Helps assess possible disease spread
- Supports staging and treatment planning
- Useful for evaluating suspected recurrence
Why Choose Molecular Diagnostics and Therapy?
- Experienced Nuclear Medicine Specialists
- Advanced PET-CT Imaging Technology
- NABL & NABH Accredited Diagnostic Centre
- Accurate and reliable reporting
- Appropriate radiation safety protocols
- Affordable and transparent pricing
- Comprehensive Nuclear Medicine, Radiology, and Pathology services under one roof
Book Your 18F-PSMA PET-CT
Schedule your 18F-PSMA PET-CT scan at Molecular Diagnostics and Therapy. Our team of nuclear medicine physicians offers functional and anatomical imaging to assist physicians in assessing prostate cancer, recurrent cancer, PSD lymph node involvement, bone metastasis, and other PSMA-expressing lesions.
Test information: Fasting NOT required.
Reporting: Within 24 hours*
- Fasting may be required depending on the scan protocol. Follow the fasting instructions provided by the Nuclear Medicine team.
- Stay adequately hydrated before and after the scan unless otherwise advised by your doctor.
- Inform the Nuclear Medicine team about your current medications, ongoing treatments, and relevant medical conditions.
- If you are pregnant, may be pregnant, or are breastfeeding, inform the Nuclear Medicine team before the scan.
- Carry previous PSA reports, PET-CT scans, CT/MRI reports, biopsy reports, treatment records, or other relevant medical documents, if available.
- Do not stop or change any prescribed medication unless specifically advised by your doctor.
- Follow all instructions regarding food, fluids, medications, and activity provided before the examination.
- Follow the radiation-safety and post-scan instructions provided by the Nuclear Medicine team.
Talk to Health Expert
Health Articles
